Deutsche Bank’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-340
| Closed | -$39K | – | 4639 |
|
|
2021
Q1 | $39K | Buy |
+340
| New | +$39K | ﹤0.01% | 4188 |
|
|
2020
Q4 | – | Sell |
-25
| Closed | -$1K | – | 4399 |
|
|
2020
Q3 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 4191 |
|
|
2020
Q1 | – | Sell |
-88
| Closed | -$8K | – | 4577 |
|
|
2019
Q4 | $8K | Sell |
88
-53
| -38% | -$4.82K | ﹤0.01% | 4332 |
|
|
2019
Q3 | $14K | Sell |
141
-817
| -85% | -$81.1K | ﹤0.01% | 4225 |
|
|
2019
Q2 | $282K | Sell |
958
-195
| -17% | -$57.4K | ﹤0.01% | 3578 |
|
|
2019
Q1 | $536K | Buy |
1,153
+913
| +380% | +$424K | ﹤0.01% | 3365 |
|
|
2018
Q4 | $70K | Buy |
240
+20
| +9% | +$5.83K | ﹤0.01% | 4161 |
|
|
2018
Q3 | $38K | Buy |
220
+3
| +1% | +$518 | ﹤0.01% | 4509 |
|
|
2018
Q2 | $42K | Sell |
217
-16
| -7% | -$3.1K | ﹤0.01% | 4557 |
|
|
2018
Q1 | $34K | Sell |
233
-169
| -42% | -$24.7K | ﹤0.01% | 4545 |
|
|
2017
Q4 | $94K | Buy |
402
+87
| +28% | +$20.3K | ﹤0.01% | 4038 |
|
|
2017
Q3 | $64K | Sell |
315
-78
| -20% | -$15.8K | ﹤0.01% | 4060 |
|
|
2017
Q2 | $38K | Sell |
393
-191
| -33% | -$18.5K | ﹤0.01% | 4150 |
|
|
2017
Q1 | $174K | Buy |
584
+73
| +14% | +$21.8K | ﹤0.01% | 3511 |
|
|
2016
Q4 | $183K | Sell |
511
-212
| -29% | -$75.9K | ﹤0.01% | 3575 |
|
|
2016
Q3 | $248K | Buy |
723
+83
| +13% | +$28.5K | ﹤0.01% | 3426 |
|
|
2016
Q2 | $208K | Buy |
640
+304
| +90% | +$98.8K | ﹤0.01% | 3633 |
|
|
2016
Q1 | $110K | Buy |
336
+219
| +187% | +$71.7K | ﹤0.01% | 3794 |
|
|
2015
Q4 | $51K | Buy |
117
+115
| +5,750% | +$50.1K | ﹤0.01% | 4107 |
|
|
2015
Q3 | $1K | Sell |
2
-29
| -94% | -$14.5K | ﹤0.01% | 4632 |
|
|
2015
Q2 | $88K | Buy |
+31
| New | +$88K | ﹤0.01% | 4057 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 5350 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 5396 |
|
|
2014
Q1 | – | Sell |
-48
| Closed | -$668K | – | 5217 |
|
|
2013
Q4 | $668K | Buy |
48
+38
| +380% | +$529K | ﹤0.01% | 2900 |
|
|
2013
Q3 | $145K | Buy |
10
+4
| +67% | +$58K | ﹤0.01% | 4257 |
|
|
2013
Q2 | $110K | Buy |
+6
| New | +$110K | ﹤0.01% | 4157 |
|